Search

AxoGen Inc

Закрыт

СекторЗдравоохранение

49.94 8.14

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

49.7

Макс.

50.58

Ключевые показатели

By Trading Economics

Доход

18M

-1.5M

Продажи

8.3M

70M

Прибыль на акцию

-0.03

Рентабельность продаж

-2.174

Сотрудники

622

EBITDA

15M

-2.2M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+9.46% upside

Дивиденды

By Acuity

Следующий отчет о доходах

28 окт. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

455M

2.6B

Предыдущая цена открытия

41.8

Предыдущая цена закрытия

49.94

Новостные настроения

By Acuity

67%

33%

307 / 340 Рейтинг в Healthcare

AxoGen Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

21 авг. 2026 г., 20:01 UTC

AxoGen Inc shares are higher today, supported by high trading volume. The stock remains above its 20-day moving average amid broader market gains.

20 авг. 2026 г., 22:46 UTC

AxoGen Inc shares are higher in after-market trading, showing notable strength above the 20-day moving average and near the upper end of its one-month range.

19 авг. 2026 г., 21:01 UTC

AxoGen Inc shares are lower in after-market trading, despite no specific news to explain the decline. The stock remains near its one-month high.

18 авг. 2026 г., 19:16 UTC

AxoGen Inc shares are higher, continuing positive momentum from Monday. The stock remains above its 20-day moving average, reflecting strong performance.

17 авг. 2026 г., 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reaching a peak above Monday's close amid broader market pressures and rising crude oil prices.

14 авг. 2026 г., 20:06 UTC

AxoGen Inc's shares are higher today amid mixed market sentiment following a decline in U.S. retail sales for July. No specific company news was identified.

13 авг. 2026 г., 22:36 UTC

AxoGen Inc. shares declined in after-market trading, despite broader market strength and earlier gains. The stock remains above recent performance averages.

12 авг. 2026 г., 19:32 UTC

AxoGen Inc shares are higher today amid strong trading volume and broader market gains, reflecting optimism from recent inflation data.

10 авг. 2026 г., 19:41 UTC

AxoGen Inc shares are higher, driven by gains in the Health Care Equipment sub-sector and unusually high market volume. The stock remains above its 20-day moving average.

7 авг. 2026 г., 20:05 UTC

AxoGen Inc shares are higher today amid strong market volume, reflecting a broader upward trend since Thursday's close.

5 авг. 2026 г., 19:46 UTC

AxoGen Inc shares are lower amid broader market caution following ADP's report of a significant miss in private sector job growth for July.

4 авг. 2026 г., 20:06 UTC

AxoGen Inc's shares are higher today, continuing a steady climb since Monday's close amid positive market sentiment and broader trends.

3 авг. 2026 г., 20:02 UTC

News

AxoGen Inc. shares are advancing as trading volume spikes amid strong interest. The company reported a 23.1% revenue increase to $69.7 million for Q2 2026.

31 июл. 2026 г., 20:06 UTC

AxoGen Inc shares are higher, recovering from an earlier dip. The stock remains above its 20-day moving average, reflecting solid overall performance.

30 июл. 2026 г., 19:24 UTC

AxoGen Inc shares are higher, supported by significant broader market gains and unusually high trading volume, despite earlier pulling back from session highs.

29 июл. 2026 г., 20:41 UTC

AxoGen Inc shares are lower in after-market trading amid a broader downturn in U.S. equities and rising crude oil prices linked to geopolitical tensions.

28 июл. 2026 г., 20:03 UTC

AxoGen Inc. shares are declining today, pulling back from an earlier high amid broader market weakness linked to declines in Asian indices.

27 июл. 2026 г., 19:16 UTC

AxoGen Inc shares are higher today, continuing a strong upward trend since Friday's close. Broader market sentiment is influenced by declining oil prices.

22 июл. 2026 г., 20:01 UTC

AxoGen Inc shares are lower in Wednesday's session amid high trading volume, continuing a decline that began Tuesday. No specific news was identified.

21 июл. 2026 г., 17:46 UTC

AxoGen Inc shares are higher today, having earlier peaked around 3.01% before pulling back. No specific news was identified to explain the movement.

20 июл. 2026 г., 19:06 UTC

AxoGen Inc. shares are lower during Monday's session, pulling back from earlier highs amid rising Treasury yields and inflation concerns linked to oil prices.

Сравнение c конкурентами

Изменение цены

AxoGen Inc Прогноз

Целевая цена

By TipRanks

9.46% рост

Прогноз на 12 месяцев

Средняя 55.17 USD  9.46%

Максимум 58 USD

Минимум 53 USD

Основано на мнении 6 аналитиков Wall Street, спрогнозировавших целевые цены для AxoGen Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

6 ratings

6

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

307 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
help-icon Live chat